These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9393189)

  • 1. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muscle uptake of 18FDG in positron emission tomography].
    Ortega F; Carreras JL; Maldonado A; Pérez-Castejón MJ; Montz R; Gorospe E; Ruiz JA; Nieto C
    Rev Esp Med Nucl; 1998; 17(2):120-1. PubMed ID: 9611283
    [No Abstract]   [Full Text] [Related]  

  • 3. Muscle uptake of 18-fluorine fluorodeoxyglucose.
    Bar-Shalom R
    Semin Nucl Med; 2000 Oct; 30(4):306-9. PubMed ID: 11105931
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron emission tomography in cancer patient management.
    Wahl RL
    Cancer J Sci Am; 1999; 5(4):205-7. PubMed ID: 10439163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Positron emission tomography (PET) in oncology (Part I)].
    Gámez Cenzano C; Cabrera Villegas A; Sopena Monforte R; García Velloso MJ
    Rev Esp Med Nucl; 2002 Feb; 21(1):41-60; quiz 61-3. PubMed ID: 11821003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
    Schelbert HR; Hoh CK; Royal HD; Brown M; Dahlbom MN; Dehdashti F; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1302-5. PubMed ID: 9669415
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
    Weckesser E; Redeker J; Kühnel G; Börner AR; Flügel M; Knapp WH
    Nuklearmedizin; 2000; 39(3):N38-9. PubMed ID: 10834199
    [No Abstract]   [Full Text] [Related]  

  • 10. SUV: standard uptake or silly useless value?
    Keyes JW
    J Nucl Med; 1995 Oct; 36(10):1836-9. PubMed ID: 7562051
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography scanning: a primer.
    Walker RC; Weiss DW; Purnell GL; Forte KF
    J Ark Med Soc; 2002 Oct; 99(4):119-21. PubMed ID: 12362654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PET?: comfortable whole body checkup].
    Hanafusa K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jun; 62(6):781-5. PubMed ID: 16856256
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
    Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
    Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
    Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T
    Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.
    Gabriel M; Erler H; Donnemiller E; Riccabona G
    Nuklearmedizin; 2002 Apr; 41(2):N14-5. PubMed ID: 11989305
    [No Abstract]   [Full Text] [Related]  

  • 18. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Using isotopes with short half-life in the diagnostics of oncological diseases].
    Minn H; Kööbi T; Ahonen A
    Duodecim; 2003; 119(1):26-32. PubMed ID: 12607469
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.
    Conrad EU; Morgan HD; Vernon C; Schuetze SM; Eary JF
    J Bone Joint Surg Am; 2004; 86-A Suppl 2():98-104. PubMed ID: 15691114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.